Deborah L. Wexler, MD, Executive Director, Immunization Action Coalition
At the beginning of each year, the Centers for Disease Control and Prevention (CDC), in collaboration with professional societies, releases updated versions of the recommended U.S. immunization schedules for children and teens as well as for adults. These updated schedules reflect changes that were made in vaccination recommendations during the previous year.
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years, U.S., 2014. This six-page schedule, which was published on the CDC website on January 31, 2014 includes the age-based routine vaccination schedule for children and teens and the approved catch-up immunization schedule for people age 4 months through 18 years who start vaccination late or who are more than one month behind. The schedule also includes three pages of essential explanatory footnotes. An article in the February 7 MMWR provides a summary of these changes.
Recommended Immunization Schedule for Adults Aged 19 Years and Older, U.S., 2014. Released by CDC on February 3, this five-page schedule for adult vaccination provides recommendations by age group as well as by medical condition, two pages of essential footnotes, and a final page summarizing the contraindications and precautions for adult vaccine use. An article in the February 7 MMWR summarizes the changes to the adult guidance.
Several additional formats of the schedules, including patient-friendly versions, are available on the CDC website.
To make your job easier, the Immunization Action Coalition (IAC) has designed two user-friendly documents that summarize the guidance contained in the current CDC/ACIP recommendations.
These summaries distill the ACIP recommendations for child, teen and adult immunization into two easy-to-use documents. Each summary includes the routine schedule, spacing between doses, schedules for catch-up vaccination, routes of administration, and contraindications and precautions for all routinely recommended vaccines in the United States.
These summaries of the recommendations have long proved their value — for almost two decades, they have been top downloads from IAC's website for busy healthcare professionals. They have been reprinted in textbooks and state health department newsletters and distributed at countless medical, nursing and public health conferences. Print the summaries on card stock and place them in every exam room for easy reference — you'll be glad you did!
In addition, IAC has developed the following specialized recommendation summaries for situations that providers often find confusing:
You can access these and more than 250 other ready-to-copy IAC materials
for healthcare professionals and patients on the IAC website.
Let’s start with the good news. Since human papillomavirus (HPV) vaccine was licensed for use in the U.S. in 2006, vaccine-type HPV prevalence has declined 56 percent among females 14 through 19 years of age.
Now for the bad news. According to the United States Centers for Disease Control and Prevention’s (CDC) most recent National Immunization Survey for teens, HPV vaccination rates did not increase at all from 2011 to 2012 in 13- to 17-year-old girls. Only half of these teens received the first dose of this anticancer vaccine, and only one-third received the full three-dose series.
Tdap and meningococcal vaccines were added to the vaccination schedule for preteens at about the same time, yet their coverage rates are much higher, 85 percent and 74 percent, respectively.
These survey results demonstrate that we are missing opportunities to vaccinate preteens against HPV. We need to do better.
Research consistently shows that a provider’s recommendation to vaccinate is the single most influential factor in convincing parents to vaccinate their children. Here are some important points to remember and statements you can make to parents when recommending HPV vaccine:
Your approach to discussing HPV vaccination with a parent strongly influences whether they have their child vaccinated. When you only ask parents if they’d like to vaccinate their child, rather than recommending it, vaccine acceptance drops significantly. Your strong recommendation is what is needed to protect our nation’s children from HPV.
We welcome your input. Please contact us with story ideas, questions or other comments: